Carbohydrate and lipid metabolism during various growth hormone dosing regimens in girls with Turner syndrome

Metabolism: Clinical and Experimental

Volumn 48, Issue 1, 1999, Pages 7-14

  Van Teunenbroek, A ^a   De Muinck Keizer Schrama, S M P F ^a   Aanstoot, H J ^a   Stijnen, T ^a   Hoogerbrugge, N ^a   Drop, S L S ^a  

^a SOPHIA CHILDREN S HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; ETHINYLESTRADIOL; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HUMAN GROWTH HORMONE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

AREA UNDER THE CURVE; ARTICLE; CARBOHYDRATE METABOLISM; CHILD; DOSE RESPONSE; DRUG EFFECT; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; HEMOGLOBIN DETERMINATION; HORMONE SUBSTITUTION; HUMAN; INSULIN RESISTANCE; LIPID METABOLISM; MAJOR CLINICAL STUDY; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; TURNER SYNDROME;

EID: 0032956687     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(99)90003-3     Document Type: Article

References (49)

1. Rother K, Zachmann M, Kempken B, et al: Effect of recombinant human growth hormone on urinary N-nitrogen balance in girls with Turner syndrome as compared to children with growth hormone deficiency. Horm Res 32:166-169, 1989
2. Pearson O, Domingnez J, Greenberg E, et al: Diabetogenic and hypoglycemia effects of human growth hormone. Trans Assoc Am Phys 73:217-226, 1973
3. Hansen I, Tsalikian E, Beaufrere B, et al: Insulin resistance in acromegaly: Defects in both hepatic and extrahepatic insulin action. Am J Physiol 250:E269-E273, 1986
4. Bratusch-Marrain PR, Smith D, Defronzo RA: The effect of growth hormone on glucose metabolism and insulin secretion in man. J Clin Endocrinol Metab 55:973-982, 1982
5. Rizza RA, Mandarino LJ, Gerich JE: Effects of growth hormone on insulin action in man. Mechanisms of insulin resistance, impaired suppression of glucose production, and impaired stimulation of glucose utilization. Diabetes 31:663-669, 1982
6. Press M, Tamborlane MW, Sherwin RS: Importance of raised growth hormone levels in mediating the metabolic derangements of diabetes. N Engl J Med 310:810-815, 1984
7. Holl RW, Heinze E: Impaired glucose tolerance and diabetes mellitus in Ullrich-Tumer-syndrome: Review of the literature. Monatsschr Kinderheilkd 139:676-680, 1991
8. Wilson DM, Frane JW, Sherman B, et al: Carbohydrate and lipid metabolism in Turner syndrome: Effect of therapy with growth hormone, oxandrolone, and a combination of both. J Pediatr 112:210-217, 1988
9. Haeusler G, Frisch H: Growth hormone treatment in Turner's syndrome: Short and long-term effects on metabolic parameters. Clin Endocrinol (Oxf) 36:247-254, 1992
10. Costin G, Kogut MD: Carbohydrate intolerance in gonadal dysgenesis: Evidence for insulin resistance and hyperglucagonemia. Horm Res 22:260-269, 1985
11. Caprio S, Boulware S, Diamond M. et al: Insulin resistance: An early metabolic defect of Turner's syndrome. J Clin Endocrinol Metab 72:832-836, 1991
12. Cicognani A, Mazzanti L, Tassinari D, et al: Differences in carbohydrate tolerance in Turner syndrome depending on age and karyotype. Eur J Pediatr 148:64-68, 1988
13. Weise M, James D, Leitner CH, et al: Glucose metabolism in Ullrich-Turner syndrome: Long-term effects of therapy with human growth hormone. Horm Res 39:36-41, 1993
14. Harant I, Beauville M, Crampes F, et al: Response of fat cells to growth hormone (GH): Effect of long-term treatment with recombinant human GH in GH-deficient adults. J Clin Endocrinol Metab 78:1392-1395, 1994
15. Bengtsson B-A, Eden S, Lonn L, et al: Treatment of adults with growth hormone (GH) deficiency with recombinant GH. J Clin Endocrinol Metab 76:309-317, 1993
16. Garry P, Collins P, Devlin JG: An open 36-month study of lipid changes with growth hormone in adults: Lipid changes following replacement of growth hormone in adult acquired growth hormone deficiency. Eur J Endocrinol 134:61-66, 1996
17. Boot AM, Engels MAMJ, Boerma GJM, et al: Changes in bone mineral density, body composition and lipid metabolism during growth hormone (GH) treatment in children with GH deficiency. J Clin Endocrinol Metab 82:2423-2428, 1997
18. Kohno H, Ueyama N, Yanai S, et al: Beneficial effect of growth hormone on atherogenic risk in children with growth hormone deficiency. J Pediatr 126:953-955, 1995
19. De Muinck Keizer-Schrama S, Rikken B, Hokken-Koelega A, et al: Comparative effect of two doses of growth hormone for growth hormone deficiency. Arch Dis Child 71:12-18, 1994
20. Schaefer GB, Greger NG, Fesmire JD, et al: Lipids and apolipoproteins in growth hormone-deficient children during treatment. Metabolism 43:1457-1461, 1994
21. Gertner JM, Tamborlane WV, Gianfredi SP, et al: Renewed catch-up growth with increased replacement doses of human growth hormone. J Pediatr 110:425-428, 1987
22. Pringle PJ, Hindmarsh PC, Stanhope RG, et al: The effect of frequency of administration of biosynthetic human growth hormone on growth rate, 24h free growth hormone profiles, carbohydrate and lipid metabolism. Horm Res 37:15,1992 (suppl, abstr)
23. Müller N, Schmitz O, Jø̂rgensen JO, et al: Basal and insulinstimulated substrate metabolism in patients with active acromegaly before and after adenectomy. J Clin Endocrinol Metab 74:1012-1019, 1992
24. Havel RJ, Goldstein JL, Brown MS: Growth hormone. J Clin Invest 82:745-747, 1988
25. Havel RJ, Goldstein JL, Brown MS: Lipoprotein and lipid transport, in Bondy PK, Rosenberg LK (eds): Metabolic Control and Disease. Philadelphia, PA, Saunders, 1980, pp 393-494
26. Stahnke N, Stubbe P, Keller E, et al: Effects and side-effects of GH plus oxandrolone in Turner syndrome, in Ranke MB, Rosenfeld R (eds): Turner Syndrome: Growth Promoting Therapies. Amsterdam, The Netherlands, Elsevier Science, 1991, pp 241-247
27. Brambilla P, Monti LD, Natale B, et al: Effect of growth hormone treatment on glucose and lipid metabolism in girls with Turner syndrome. Horm Res 37:26, 1992 (suppl, abstr)
28. Roede MJ, Van Wieringen JC: Growth diagrams 1980. Netherlands third nationwide survey. Tijdschr Soc Gezondh 63:1-34, 1985 (suppl)
29. Tanner JM, Whitehouse RH: Clinical longitudinal standards for height, weight, height velocity, weight velocity, and stages of puberty. Arch Dis Child 51:170-179, 1976
30. Van Teunenbroek A, de Muinck Keizer-Schrama SMPF, Stijnen T, et al: Effect of growth hormone administration frequency on 24-hour growth hormone profiles and levels of other growth related parameters in girls with Turner's syndrome. Clin Endocrinol (Oxf) 39:77-84, 1993
31. National Diabetes Data Group: Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 28:1039-1057, 1979
32. Seltzer HS, Smith WL: Plasma insulin activity after glucose: An index of insulinogenic reserve in normal and diabetic man. Diabetes 8:417-424, 1959
33. Gent CM, Voort HA, Bruijn AM, et al: Cholesterol determinations. A comparative study of methods with special reference to enzymatic procedures. Clin Chim Acta 75:243-251, 1977
34. Grove TH: Effect of reagent pH on determination of high-density lipoprotein cholesterol by precipitation with sodium phosphotungstate-magnesium. Clin Chim Acta 25:560-564, 1979
35. Rolland-Cachera MF, Sempe M, Guilloud-Bataille M, et al: Adiposity indices in children. Am J Clin Nutr 78:178-184, 1982
36. Tanaka T, Sato M, Tanae A, et al: Glucose tolerance in Turner syndrome, in Hibi I, Tanako K (eds): Basic and Clinical Approach to Turner syndrome. Amsterdam, The Netherlands, Elsevier Science, 1993, pp 107-112
37. Takano K, Shizume K, Hibi I, et al: Treatment of 46 patients with Turner's syndrome with recombinant human growth hormone (YM-17798) for three years: A multicentre study. Acta Endocrinol (Copenh) 126:296-302, 1992
38. Wilson DM, Rosenfeld RG, Genentech Turner Collaborative Group: Effect of GH and oxandrolone on carbohydrate and lipid metabolism, in Ranke MB, Rosenfeld R (eds): Turner Syndrome: Growth Promoting Therapies. Amsterdam, The Netherlands, Elsevier Science, 1991, pp 269-274
39. De Schepper J, Craen M, Massa G, et al: Growth hormone therapy in Turner's syndrome: One versus two daily injections. J Clin Endocrinol Metab 79:489-494, 1994
40. Mortensen HB, Hougaard P, Hvidore Study Group on Childhood Diabetes: Comparison of metabolic control in a cross-sectional study of 2,873 children and adolescents with IDDM from 18 countries. Diabetes Care 20:714-721, 1997
41. Takano K, Hizuka N, Shizume K: Growth hormone treatment in Turner's syndrome. Acta Paediatr Scand Suppl 325:58-63, 1986
42. De Beaufort CE, de Boer NC, Bruining GJ, et al: Urinary C-peptide: A useful tool for evaluating the endogenous insulin reserve in cohort and longitudinal studies of diabetes in childhood. Ann Clin Biochem 25:552-559, 1988
43. Modan M, Halkin H, Almog S, et al: Hyperinsulinemia: A link between hypertension, obesity, and glucose intolerance. J Clin Invest 75:809-817, 1985
44. Van Stiphout WAHJ, Hofman A, de Bruijn AM, et al: Distributions and determinants of total and high-density lipoprotein cholesterol in Dutch children and young adults. Prev Med 14:169-180, 1985
45. Ross JL, Feuillan P, Long LM, et al: Lipid abnormalities in Turner syndrome. J Pediatr 126:242-245, 1995
46. Friday KE, Drinkwater BL, Bruemmer B, et al: Elevated plasma low-density lipoprotein and high-density lipoprotein cholesterol level in amenorrheic athletes: Effects of endogenous hormone status and nutrient intake. J Clin Endocrinol Metab 77:1605-1609, 1993
47. Freedman DS, Srinivasan SR, Harsha DW: Relation of body fat patterning to lipid and lipoprotein concentration in children and adolescents: The Bogalusa Heart Study. Am J Clin Nutr 50:930-939, 1989
48. Gillmann MW, Cupples LA, Moore LL, et al: Impact of within-person variability on identifying children with hypercholesterolemia: Framingham Children's Study. J Pediatr 121:342-347, 1992
49. Asayama K, Amemiya S, Kusano S, et al: Growth-hormone-induced changes in postheparin plasma lipoprotein lipase and hepatic triglyceride lipase activities. Metabolism 33:129-131, 1984